secwatch.observer — SEC 8-K summary
======================================

Issuer:     Oric Pharmaceuticals, Inc. (ORIC)
CIK:        0001796280
Form:       8-K
Filed at:   2025-03-14T23:59:59+00:00
Accession:  0001193125-25-054784
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ORIC Pharmaceuticals amends inducement equity plan, adds 1.1M shares to reserve
-------------------------------------------------------------------------------

- Compensation Committee approved Amended and Restated 2022 Inducement Plan, adding 1,100,000 shares to reserve.
- Total shares reserved under the plan increased to 2,250,000 shares.
- Amendment adopted without stockholder approval under Nasdaq Listing Rules.
- Awards are inducement material for new employees and non-employee directors under Nasdaq Rule 5635(c)(4).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1796280/000119312525054784/0001193125-25-054784-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1796280/000119312525054784/d873253d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-054784

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer